EveliQure Biotechnologies GmbH
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.eveliqure.com
Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Not Applicable
1 (33.3%)Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old
Not Applicable
Recruiting
- Conditions
- Shigella
- Interventions
- Biological: ShigETEC vaccineOther: Placebo
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Eveliqure Biotechnologies GmbH
- Target Recruit Count
- 72
- Registration Number
- NCT07049159
- Locations
- 🇺🇸
Center for Immunization Research, Baltimore, Maryland, United States
ShigETEC Vaccine Study in Bangladesh
Phase 1
Recruiting
- Conditions
- Healthy Volunteers
- Interventions
- Other: Placebo
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Eveliqure Biotechnologies GmbH
- Target Recruit Count
- 180
- Registration Number
- NCT05987488
- Locations
- 🇧🇩
International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults
Phase 1
Completed
- Conditions
- Gastrointestinal DiseaseReactive ArthritisDiarrheal Disease, Infectious
- Interventions
- Biological: ShigETEC live, attenuated, oral vaccineDrug: Placebo
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- Eveliqure Biotechnologies GmbH
- Target Recruit Count
- 84
- Registration Number
- NCT05409196
- Locations
- 🇭🇺
Debreceni Egyetem, Klinikai Központ, Belgyógyászati Klinika, Klinikai Farmakológiai Részleg, Debrecen, Hungary
News
No news found
